{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:47:36Z","timestamp":1769604456014,"version":"3.49.0"},"reference-count":25,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,2,14]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>Telomere length in MCL is variable but does not correlate with disease characteristics and survival.<\/jats:p>","DOI":"10.1182\/blood-2012-08-452649","type":"journal-article","created":{"date-parts":[[2012,12,16]],"date-time":"2012-12-16T01:46:10Z","timestamp":1355622370000},"page":"1184-1187","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":18,"title":["Telomere length in mantle cell lymphoma"],"prefix":"10.1182","volume":"121","author":[{"given":"Billy Michael Chelliah","family":"Jebaraj","sequence":"first","affiliation":[{"name":"Department of Internal Medicine III, University of Ulm, Ulm, Germany;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Kienle","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, University of Ulm, Ulm, Germany;"},{"name":"Department of Hematology\/Oncology, Triemli Hospital, Zurich, Switzerland;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Lechel","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, University of Ulm, Ulm, Germany;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Mertens","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, University of Ulm, Ulm, Germany;"},{"name":"Cooperation Unit \u201cMechanisms of Leukemogenesis,\u201d German Cancer Research Center (DKFZ), Heidelberg, Germany;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Heuberger","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, University of Ulm, Ulm, Germany;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"German","family":"Ott","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathology, Robert-Bosch-Krankenhaus and Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Rosenwald","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of W\u00fcrzburg, W\u00fcrzburg, Germany;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas F. E.","family":"Barth","sequence":"additional","affiliation":[{"name":"Institute for Pathology, University of Ulm, Ulm, Germany;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"M\u00f6ller","sequence":"additional","affiliation":[{"name":"Institute for Pathology, University of Ulm, Ulm, Germany;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thorsten","family":"Zenz","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, University of Ulm, Ulm, Germany;"},{"name":"Department of Translational Oncology, National Center for Tumor Diseases, and German Cancer Research Center, Heidelberg, Germany; and"},{"name":"Department of Medicine V, University of Heidelberg, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hartmut","family":"D\u00f6hner","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, University of Ulm, Ulm, Germany;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Stilgenbauer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, University of Ulm, Ulm, Germany;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"4","key":"2019111816123244400_B1","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1200\/JCO.2008.16.8435","article-title":"Improvement of overall survival in advanced stage mantle cell lymphoma.","volume":"27","author":"Herrmann","year":"2009","journal-title":"J Clin Oncol"},{"issue":"5","key":"2019111816123244400_B2","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3324\/haematol.12330","article-title":"Genomic aberrations in mantle cell lymphoma detected by interphase fluorescence in situ hybridization. Incidence and clinicopathological correlations.","volume":"93","author":"Sander","year":"2008","journal-title":"Haematologica"},{"issue":"6","key":"2019111816123244400_B3","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1182\/blood-2010-01-263806","article-title":"Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling.","volume":"116","author":"Hartmann","year":"2010","journal-title":"Blood"},{"issue":"8","key":"2019111816123244400_B4","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1182\/blood-2003-05-1383","article-title":"VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcome.","volume":"102","author":"Kienle","year":"2003","journal-title":"Blood"},{"issue":"11","key":"2019111816123244400_B5","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1182\/blood-2011-03-343434","article-title":"Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases.","volume":"118","author":"Hadzidimitriou","year":"2011","journal-title":"Blood"},{"issue":"6","key":"2019111816123244400_B6","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1073\/pnas.050400997","article-title":"Mantle cell lymphoma is characterized by inactivation of the ATM gene.","volume":"97","author":"Schaffner","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"2019111816123244400_B7","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1182\/blood.V87.8.3351.bloodjournal8783351","article-title":"p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas.","volume":"87","author":"Hernandez","year":"1996","journal-title":"Blood"},{"issue":"11","key":"2019111816123244400_B8","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.1182\/blood-2006-08-039859","article-title":"Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival.","volume":"109","author":"Wiestner","year":"2007","journal-title":"Blood"},{"issue":"9","key":"2019111816123244400_B9","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1182\/blood-2011-11-391474","article-title":"Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma.","volume":"119","author":"Kridel","year":"2012","journal-title":"Blood"},{"issue":"8","key":"2019111816123244400_B10","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1182\/blood-2005-10-4079","article-title":"The Ki67 proliferation index is a quantitative indicator of clinical risk in mantle cell lymphoma.","volume":"107","author":"Katzenberger","year":"2006","journal-title":"Blood"},{"issue":"2","key":"2019111816123244400_B11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1535-6108(03)00028-X","article-title":"The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma.","volume":"3","author":"Rosenwald","year":"2003","journal-title":"Cancer Cell"},{"issue":"4","key":"2019111816123244400_B12","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1158\/0008-5472.CAN-09-3419","article-title":"Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma.","volume":"70","author":"Fern\u00e0ndez","year":"2010","journal-title":"Cancer Res"},{"issue":"2","key":"2019111816123244400_B13","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1182\/blood-2007-06-095331","article-title":"A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma.","volume":"111","author":"Hoster","year":"2008","journal-title":"Blood"},{"issue":"6","key":"2019111816123244400_B14","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1172\/JCI61745","article-title":"Transient telomere dysfunction induces chromosomal instability and promotes carcinogenesis.","volume":"122","author":"Begus-Nahrmann","year":"2012","journal-title":"J Clin Invest"},{"issue":"2","key":"2019111816123244400_B15","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1182\/blood-2003-04-1345","article-title":"Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations.","volume":"103","author":"Damle","year":"2004","journal-title":"Blood"},{"issue":"4","key":"2019111816123244400_B16","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1182\/blood-2007-05-092759","article-title":"Short telomeres are associated with genetic complexity, high-risk genomic aberrations, and short survival in chronic lymphocytic leukemia.","volume":"111","author":"Roos","year":"2008","journal-title":"Blood"},{"issue":"1","key":"2019111816123244400_B17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3324\/haematol.2011.049874","article-title":"Telomere length and telomerase levels delineate subgroups of B-cell chronic lymphocytic leukemia with different biological characteristics and clinical outcomes.","volume":"97","author":"Rampazzo","year":"2012","journal-title":"Haematologica"},{"issue":"5","key":"2019111816123244400_B18","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1600-0609.2009.01313.x","article-title":"Analysis of telomere length in mantle cell lymphoma.","volume":"83","author":"Cottliar","year":"2009","journal-title":"Eur J Haematol"},{"issue":"12","key":"2019111816123244400_B19","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.1182\/blood-2003-12-4412","article-title":"Telomere length correlates with histo- pathogenesis according to the germinal center in mature B-cell lymphoproliferative disorders.","volume":"103","author":"Ladetto","year":"2004","journal-title":"Blood"},{"issue":"4","key":"2019111816123244400_B20","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1600-0609.2007.00817.x","article-title":"Telomere length and correlation with histopathogenesis in B-cell leukemias\/lymphomas.","volume":"78","author":"Walsh","year":"2007","journal-title":"Eur J Haematol"},{"issue":"13","key":"2019111816123244400_B21","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1182\/blood-2009-05-224071","article-title":"Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trial.","volume":"114","author":"Zenz","year":"2009","journal-title":"Blood"},{"issue":"3","key":"2019111816123244400_B22","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1182\/blood-2003-12-4175","article-title":"Genomic DNA-chip hybridization in t(11;14)-positive mantle cell lymphomas shows a high frequency of aberrations and allows a refined characterization of consensus regions.","volume":"104","author":"Kohlhammer","year":"2004","journal-title":"Blood"},{"issue":"6","key":"2019111816123244400_B23","doi-asserted-by":"crossref","first-page":"807","DOI":"10.2144\/000112761","article-title":"A quantitative real-time PCR method for absolute telomere length.","volume":"44","author":"O'Callaghan","year":"2008","journal-title":"Biotechniques"},{"issue":"10","key":"2019111816123244400_B24","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/30.10.e47","article-title":"Telomere measurement by quantitative PCR.","volume":"30","author":"Cawthon","year":"2002","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2019111816123244400_B25","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1073\/pnas.92.1.258","article-title":"DNA damage and repair in telomeres: Relation to aging.","volume":"92","author":"Kruk","year":"1995","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/7\/1184\/1367618\/zh800713001184.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/7\/1184\/1367618\/zh800713001184.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T21:12:45Z","timestamp":1574111565000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/121\/7\/1184\/31501\/Telomere-length-in-mantle-cell-lymphoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,14]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,2,14]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-08-452649","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,14]]}}}